Previous close | 123.50 |
Open | 129.08 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 124.64 - 129.08 |
52-week range | 74.70 - 140.32 |
Volume | |
Avg. volume | 42,548 |
Market cap | 577.889B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 48.19 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.86 (1.51%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
Earnings preview of key companies reporting next week and what to look out for.
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.